News & Events about Mimedx Group Inc.
Highly experienced and accomplished three-time healthcare CEO with a proven track record of substantial value creation to lead MIMEDX MARIETTA, Ga., Jan. 30, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), a pioneer and leader in placental biologics, today ...
Fourth quarter and full year 2022 net sales expected in the ranges of $73 million to $76 million and $266 million to $269 million, respectively Provides commentary regarding the potential impact of recently published Medicare reimbursement proposals on its wound care products MARIETTA, Ga., Jan. 09...
MIMEDX bolsters management team with 30+ year MedTech veteran with extensive operational leadership MARIETTA, Ga., Jan. 03, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), a pioneer and leader in placental biologics, today announced that it has appointed Ricci S. ...
Agreement provides MIMEDX with exclusive rights to Turns PermaFusion proprietary antimicrobial intellectual property (IP), accelerating the product development pipeline for wound and surgical recovery applications MARIETTA, Ga., Dec. 08, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (...
Globe Newswire
5 months ago
The Cato T. Laurencin Regenerative Engineering Founders Award Promotes Advancement of Scientific Leadership and Research in the Field of Regenerative Engineering MARIETTA, Ga., Aug. 26, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), a transformational placental ...